Back
Nektar Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$0.64
Seasonality Move:
0.02%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.77 | Sell |
| 200-day SMA: | 1.08 | Sell |
| 8-day EMA: | 0.61 | Buy |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.75 | Sell |
| 200-day EMA: | 0.98 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 45.45 | Sell |
| Chaikin Money Flow: | 557578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.84) | Sell |
| Bollinger Bands (100): | (0.71 - 1.03) | Sell |
Nektar Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.64 while NKTR 8-day simple moving average is 0.58, which is a Buy signal.
-
The stock price of NKTR is 0.64 while Nektar Therapeutics 20-day SMA is 0.65, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 0.77 while NKTR share price is 0.64, making it a Sell technically.
-
NKTR stock price is 0.64 and Nektar Therapeutics 200-day simple moving average is 1.08, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.64. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
118.4M
Price in USD:
0.64
Share Volume:
2M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.43
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.64 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.64 while NKTR 8-day exponential moving average is 0.61, which is a Buy signal.
-
The stock price of NKTR is 0.64 while Nektar Therapeutics 20-day EMA is 0.65, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 0.75 while NKTR share price is 0.64, making it a Sell technically.
-
NKTR stock price is 0.64 and Nektar Therapeutics 200-day simple moving average is 0.98, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 45.45, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.56 - 0.84), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.71 - 1.03), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.